These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20701719)

  • 1. Omega-3 fatty acid supplementation in advanced kidney disease.
    Friedman AN
    Semin Dial; 2010; 23(4):396-400. PubMed ID: 20701719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored.
    Calder PC
    Clin Sci (Lond); 2004 Jul; 107(1):1-11. PubMed ID: 15132735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
    Madsen T; Schmidt EB; Christensen JH
    J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fish oils for cardiovascular disease: Impact on diabetes.
    Rudkowska I
    Maturitas; 2010 Sep; 67(1):25-8. PubMed ID: 20493648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the effects of omega-3 supplementation in dialysis patients.
    Friedman A; Moe S
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):182-92. PubMed ID: 17699207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of omega 3 and omega 6 fatty acid intakes from diet and supplements on plasma fatty acid levels in the first 3 years of life.
    Hoyos C; Almqvist C; Garden F; Xuan W; Oddy WH; Marks GB; Webb KL
    Asia Pac J Clin Nutr; 2008; 17(4):552-7. PubMed ID: 19114389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease.
    Sijben JW; Calder PC
    Proc Nutr Soc; 2007 May; 66(2):237-59. PubMed ID: 17466105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 polyunsaturated fatty acids in the treatment of kidney disease.
    Fassett RG; Gobe GC; Peake JM; Coombes JS
    Am J Kidney Dis; 2010 Oct; 56(4):728-42. PubMed ID: 20493605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Omega-3 fatty acids, fish, fish oil and cardiovascular disease--a review with implications to Israeli nutritional guidelines].
    Eilat-Adar S; Lipovetzky N; Goldbourt U; Henkin Y
    Harefuah; 2004 Aug; 143(8):585-91, 622, 621. PubMed ID: 15523812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 fatty acids and the cardiometabolic syndrome.
    Juturu V
    J Cardiometab Syndr; 2008; 3(4):244-53. PubMed ID: 19040594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
    Bays HE; Tighe AP; Sadovsky R; Davidson MH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):391-409. PubMed ID: 18327998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 fatty acids from fish oils and cardiovascular disease.
    Holub DJ; Holub BJ
    Mol Cell Biochem; 2004 Aug; 263(1-2):217-25. PubMed ID: 15524182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary omega-3 polyunsaturated fatty acid supplementation and airway hyperresponsiveness in asthma.
    Mickleborough TD
    J Asthma; 2005 Jun; 42(5):305-14. PubMed ID: 16036405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention.
    Russo GL
    Biochem Pharmacol; 2009 Mar; 77(6):937-46. PubMed ID: 19022225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study.
    Dyerberg J; Eskesen DC; Andersen PW; Astrup A; Buemann B; Christensen JH; Clausen P; Rasmussen BF; Schmidt EB; Tholstrup T; Toft E; Toubro S; Stender S
    Eur J Clin Nutr; 2004 Jul; 58(7):1062-70. PubMed ID: 15220949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis.
    Friedman AN; Moe SM; Perkins SM; Li Y; Watkins BA
    Am J Kidney Dis; 2006 Jun; 47(6):1064-71. PubMed ID: 16731302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids.
    Adkins Y; Kelley DS
    J Nutr Biochem; 2010 Sep; 21(9):781-92. PubMed ID: 20382009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
    Lavie CJ; Milani RV; Mehra MR; Ventura HO
    J Am Coll Cardiol; 2009 Aug; 54(7):585-94. PubMed ID: 19660687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 (n-3) fatty acids, cardiovascular disease and stability of atherosclerotic plaques.
    Calder PC; Yaqoob P
    Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):28-37. PubMed ID: 20196967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
    Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
    Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.